Loading…

Managing recurrent portal steal in auxiliary liver transplantation for non‐cirrhotic metabolic liver disease

Background APOLT has been proposed as a treatment modality for certain types of NCMLD. While the short‐term outcomes of this operation have been comparable with orthotopic LT, its long‐term outcomes have sparsely been reported. We present one such case of Citrullinemia type I who underwent APOLT and...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric transplantation 2022-12, Vol.26 (8), p.n/a
Main Authors: Vasudevan, Anu K., Shanmugam, Naresh P., Rammohan, Ashwin, Rela, Mohamed
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2319-ff6eba5c749ae61bb4b457793d089aba26e2fbc6b3156480aa78c88875445e833
cites cdi_FETCH-LOGICAL-c2319-ff6eba5c749ae61bb4b457793d089aba26e2fbc6b3156480aa78c88875445e833
container_end_page n/a
container_issue 8
container_start_page
container_title Pediatric transplantation
container_volume 26
creator Vasudevan, Anu K.
Shanmugam, Naresh P.
Rammohan, Ashwin
Rela, Mohamed
description Background APOLT has been proposed as a treatment modality for certain types of NCMLD. While the short‐term outcomes of this operation have been comparable with orthotopic LT, its long‐term outcomes have sparsely been reported. We present one such case of Citrullinemia type I who underwent APOLT and developed recurrent PS. Case Report A 2‐year‐old male child with a diagnosis of Citrullinemia type I underwent APOLT with a left lateral segment from a split deceased donor liver, and his postoperative period was unremarkable. Ammonia‐lowering agents were stopped 1 week following the operation and the child was discharged home on a normal diet. Four years following APOLT, the child presented with altered sensorium and seizures. A diagnosis of PS was made. Subsequent to an embolization of the native liver's right anterior portal vein his sensorium improved and he remained clinically stable on a normal diet. Six years following the APOLT, the child again presented with features of acute encephalopathy. Imaging was suggestive of PS. A portal vein embolization of the native portal vein was performed and the child's clinical condition improved. At 6 months' follow‐up, the child remains well on a normal diet. Conclusions While the early impediments in this technique may have been overcome, in the absence of any realistic clinical application gene therapy, the debate of long‐term phenotypic metabolic correction for NCMLD by APOLT needs to be revisited.
doi_str_mv 10.1111/petr.14389
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2736101615</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2736101615</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2319-ff6eba5c749ae61bb4b457793d089aba26e2fbc6b3156480aa78c88875445e833</originalsourceid><addsrcrecordid>eNp9kE1OwzAQhS0EEqWw4QSW2CGlxLHzt0RV-ZGKQKisrbHrFFepHWwH6I4jcEZOgtuwZhYzb_HNjN5D6JykExLrqlPBTQijVX2ARoTWdUJTVhzudZlQwrJjdOL9Ok1JwSo2QuYBDKy0WWGnZO-cMgF31gVosQ8qdm0w9J-61eC2uNXvyuHgwPiuBRMgaGtwYx021vx8fUvt3KsNWuKNCiBsG9Wws9RegVen6KiB1quzvzlGLzezxfQumT_e3k-v54nMKKmTpimUgFyWrAZVECGYYHlZ1nSZVjUIyAqVNUIWgpI8-kgBykpWVVXmjOWqonSMLoa7nbNvvfKBr23vTHzJs5IWJNoneaQuB0o6671TDe-c3kSjnKR8lyff5cn3eUaYDPCHbtX2H5I_zRbPw84vDq57xA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2736101615</pqid></control><display><type>article</type><title>Managing recurrent portal steal in auxiliary liver transplantation for non‐cirrhotic metabolic liver disease</title><source>Wiley</source><creator>Vasudevan, Anu K. ; Shanmugam, Naresh P. ; Rammohan, Ashwin ; Rela, Mohamed</creator><creatorcontrib>Vasudevan, Anu K. ; Shanmugam, Naresh P. ; Rammohan, Ashwin ; Rela, Mohamed</creatorcontrib><description>Background APOLT has been proposed as a treatment modality for certain types of NCMLD. While the short‐term outcomes of this operation have been comparable with orthotopic LT, its long‐term outcomes have sparsely been reported. We present one such case of Citrullinemia type I who underwent APOLT and developed recurrent PS. Case Report A 2‐year‐old male child with a diagnosis of Citrullinemia type I underwent APOLT with a left lateral segment from a split deceased donor liver, and his postoperative period was unremarkable. Ammonia‐lowering agents were stopped 1 week following the operation and the child was discharged home on a normal diet. Four years following APOLT, the child presented with altered sensorium and seizures. A diagnosis of PS was made. Subsequent to an embolization of the native liver's right anterior portal vein his sensorium improved and he remained clinically stable on a normal diet. Six years following the APOLT, the child again presented with features of acute encephalopathy. Imaging was suggestive of PS. A portal vein embolization of the native portal vein was performed and the child's clinical condition improved. At 6 months' follow‐up, the child remains well on a normal diet. Conclusions While the early impediments in this technique may have been overcome, in the absence of any realistic clinical application gene therapy, the debate of long‐term phenotypic metabolic correction for NCMLD by APOLT needs to be revisited.</description><identifier>ISSN: 1397-3142</identifier><identifier>EISSN: 1399-3046</identifier><identifier>DOI: 10.1111/petr.14389</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc</publisher><subject>Ammonia ; CTLN1 ; Diagnosis ; Diet ; Embolization ; Encephalopathy ; Gene therapy ; Liver ; Liver diseases ; Liver transplantation ; Liver transplants ; metabolic profile ; Metabolism ; NCMLD ; Portal vein ; PVE ; Seizures</subject><ispartof>Pediatric transplantation, 2022-12, Vol.26 (8), p.n/a</ispartof><rights>2022 Wiley Periodicals LLC.</rights><rights>2022 Wiley Periodicals, LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2319-ff6eba5c749ae61bb4b457793d089aba26e2fbc6b3156480aa78c88875445e833</citedby><cites>FETCH-LOGICAL-c2319-ff6eba5c749ae61bb4b457793d089aba26e2fbc6b3156480aa78c88875445e833</cites><orcidid>0000-0001-9528-8892 ; 0000-0003-3342-6326</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fpetr.14389$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fpetr.14389$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,786,790,27957,27958,50923,51032</link.rule.ids></links><search><creatorcontrib>Vasudevan, Anu K.</creatorcontrib><creatorcontrib>Shanmugam, Naresh P.</creatorcontrib><creatorcontrib>Rammohan, Ashwin</creatorcontrib><creatorcontrib>Rela, Mohamed</creatorcontrib><title>Managing recurrent portal steal in auxiliary liver transplantation for non‐cirrhotic metabolic liver disease</title><title>Pediatric transplantation</title><description>Background APOLT has been proposed as a treatment modality for certain types of NCMLD. While the short‐term outcomes of this operation have been comparable with orthotopic LT, its long‐term outcomes have sparsely been reported. We present one such case of Citrullinemia type I who underwent APOLT and developed recurrent PS. Case Report A 2‐year‐old male child with a diagnosis of Citrullinemia type I underwent APOLT with a left lateral segment from a split deceased donor liver, and his postoperative period was unremarkable. Ammonia‐lowering agents were stopped 1 week following the operation and the child was discharged home on a normal diet. Four years following APOLT, the child presented with altered sensorium and seizures. A diagnosis of PS was made. Subsequent to an embolization of the native liver's right anterior portal vein his sensorium improved and he remained clinically stable on a normal diet. Six years following the APOLT, the child again presented with features of acute encephalopathy. Imaging was suggestive of PS. A portal vein embolization of the native portal vein was performed and the child's clinical condition improved. At 6 months' follow‐up, the child remains well on a normal diet. Conclusions While the early impediments in this technique may have been overcome, in the absence of any realistic clinical application gene therapy, the debate of long‐term phenotypic metabolic correction for NCMLD by APOLT needs to be revisited.</description><subject>Ammonia</subject><subject>CTLN1</subject><subject>Diagnosis</subject><subject>Diet</subject><subject>Embolization</subject><subject>Encephalopathy</subject><subject>Gene therapy</subject><subject>Liver</subject><subject>Liver diseases</subject><subject>Liver transplantation</subject><subject>Liver transplants</subject><subject>metabolic profile</subject><subject>Metabolism</subject><subject>NCMLD</subject><subject>Portal vein</subject><subject>PVE</subject><subject>Seizures</subject><issn>1397-3142</issn><issn>1399-3046</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kE1OwzAQhS0EEqWw4QSW2CGlxLHzt0RV-ZGKQKisrbHrFFepHWwH6I4jcEZOgtuwZhYzb_HNjN5D6JykExLrqlPBTQijVX2ARoTWdUJTVhzudZlQwrJjdOL9Ok1JwSo2QuYBDKy0WWGnZO-cMgF31gVosQ8qdm0w9J-61eC2uNXvyuHgwPiuBRMgaGtwYx021vx8fUvt3KsNWuKNCiBsG9Wws9RegVen6KiB1quzvzlGLzezxfQumT_e3k-v54nMKKmTpimUgFyWrAZVECGYYHlZ1nSZVjUIyAqVNUIWgpI8-kgBykpWVVXmjOWqonSMLoa7nbNvvfKBr23vTHzJs5IWJNoneaQuB0o6671TDe-c3kSjnKR8lyff5cn3eUaYDPCHbtX2H5I_zRbPw84vDq57xA</recordid><startdate>202212</startdate><enddate>202212</enddate><creator>Vasudevan, Anu K.</creator><creator>Shanmugam, Naresh P.</creator><creator>Rammohan, Ashwin</creator><creator>Rela, Mohamed</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><orcidid>https://orcid.org/0000-0001-9528-8892</orcidid><orcidid>https://orcid.org/0000-0003-3342-6326</orcidid></search><sort><creationdate>202212</creationdate><title>Managing recurrent portal steal in auxiliary liver transplantation for non‐cirrhotic metabolic liver disease</title><author>Vasudevan, Anu K. ; Shanmugam, Naresh P. ; Rammohan, Ashwin ; Rela, Mohamed</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2319-ff6eba5c749ae61bb4b457793d089aba26e2fbc6b3156480aa78c88875445e833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Ammonia</topic><topic>CTLN1</topic><topic>Diagnosis</topic><topic>Diet</topic><topic>Embolization</topic><topic>Encephalopathy</topic><topic>Gene therapy</topic><topic>Liver</topic><topic>Liver diseases</topic><topic>Liver transplantation</topic><topic>Liver transplants</topic><topic>metabolic profile</topic><topic>Metabolism</topic><topic>NCMLD</topic><topic>Portal vein</topic><topic>PVE</topic><topic>Seizures</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vasudevan, Anu K.</creatorcontrib><creatorcontrib>Shanmugam, Naresh P.</creatorcontrib><creatorcontrib>Rammohan, Ashwin</creatorcontrib><creatorcontrib>Rela, Mohamed</creatorcontrib><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Pediatric transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vasudevan, Anu K.</au><au>Shanmugam, Naresh P.</au><au>Rammohan, Ashwin</au><au>Rela, Mohamed</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Managing recurrent portal steal in auxiliary liver transplantation for non‐cirrhotic metabolic liver disease</atitle><jtitle>Pediatric transplantation</jtitle><date>2022-12</date><risdate>2022</risdate><volume>26</volume><issue>8</issue><epage>n/a</epage><issn>1397-3142</issn><eissn>1399-3046</eissn><abstract>Background APOLT has been proposed as a treatment modality for certain types of NCMLD. While the short‐term outcomes of this operation have been comparable with orthotopic LT, its long‐term outcomes have sparsely been reported. We present one such case of Citrullinemia type I who underwent APOLT and developed recurrent PS. Case Report A 2‐year‐old male child with a diagnosis of Citrullinemia type I underwent APOLT with a left lateral segment from a split deceased donor liver, and his postoperative period was unremarkable. Ammonia‐lowering agents were stopped 1 week following the operation and the child was discharged home on a normal diet. Four years following APOLT, the child presented with altered sensorium and seizures. A diagnosis of PS was made. Subsequent to an embolization of the native liver's right anterior portal vein his sensorium improved and he remained clinically stable on a normal diet. Six years following the APOLT, the child again presented with features of acute encephalopathy. Imaging was suggestive of PS. A portal vein embolization of the native portal vein was performed and the child's clinical condition improved. At 6 months' follow‐up, the child remains well on a normal diet. Conclusions While the early impediments in this technique may have been overcome, in the absence of any realistic clinical application gene therapy, the debate of long‐term phenotypic metabolic correction for NCMLD by APOLT needs to be revisited.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1111/petr.14389</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-9528-8892</orcidid><orcidid>https://orcid.org/0000-0003-3342-6326</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1397-3142
ispartof Pediatric transplantation, 2022-12, Vol.26 (8), p.n/a
issn 1397-3142
1399-3046
language eng
recordid cdi_proquest_journals_2736101615
source Wiley
subjects Ammonia
CTLN1
Diagnosis
Diet
Embolization
Encephalopathy
Gene therapy
Liver
Liver diseases
Liver transplantation
Liver transplants
metabolic profile
Metabolism
NCMLD
Portal vein
PVE
Seizures
title Managing recurrent portal steal in auxiliary liver transplantation for non‐cirrhotic metabolic liver disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T23%3A16%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Managing%20recurrent%20portal%20steal%20in%20auxiliary%20liver%20transplantation%20for%20non%E2%80%90cirrhotic%20metabolic%20liver%20disease&rft.jtitle=Pediatric%20transplantation&rft.au=Vasudevan,%20Anu%20K.&rft.date=2022-12&rft.volume=26&rft.issue=8&rft.epage=n/a&rft.issn=1397-3142&rft.eissn=1399-3046&rft_id=info:doi/10.1111/petr.14389&rft_dat=%3Cproquest_cross%3E2736101615%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2319-ff6eba5c749ae61bb4b457793d089aba26e2fbc6b3156480aa78c88875445e833%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2736101615&rft_id=info:pmid/&rfr_iscdi=true